Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;53(3):291-294.
doi: 10.1016/j.dld.2020.10.035. Epub 2020 Nov 5.

Trust in telemedicine from IBD outpatients during the COVID-19 pandemic

Affiliations

Trust in telemedicine from IBD outpatients during the COVID-19 pandemic

A Costantino et al. Dig Liver Dis. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest AC received lecturer fees from Takeda, a sponsorship from Bracco, FC served as a consultant to: Mundipharma, Abbvie, MSD, Takeda, Janssen, Roche, Celgene. FC received lecturer fees from Abbvie, Ferring, Takeda, Allergy Therapeutics, Janssen and unrestricted research grants from Giuliani, Sofar, MSD, Takeda, Abbvie. MV served as consultant to: Abbvie, MSD, Takeda, Janssen-Cilag, Celgene. He received lecturer fees from Abbvie, Ferring, Takeda, MSD, Janssen-Cilag, Zambon. All the remaining authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
A radar chart of the trust scores from IBD patients, assessed through an adapted version of the PAtient Trust Assessment Tool (PATAT) questionnaire. Five trust areas are investigated: care organization (1.1–1.5), care professionals (2.1–2.5), treatment (3.1–3.5), technology (4.1–4.5) and telemedicine services (5.1–5.5). The continuous line refers to the patients giving a score ≥ 4 (out of 5) in a Likert Scale. The dotted line refers to the patients giving a score ≤ 3. Statements 2.5, 3.4, 5.3 and 5.5 were negative. Regarding the trust in telemedicine services, items 5.1, 5.2 and 5.4 received a score of least 4 in 95%, 90% and 84% of the cases, respectively.

References

    1. Dorsey E.R., Topol E.J. State of telehealth. N Engl J Med. 2016;375(2):154–161. - PubMed
    1. Daschle T., Dorsey E.R. The return of the house call. Ann Intern Med. 2015;162(8):587–588. - PubMed
    1. Toruner M., Loftus E.V., Jr, Harmsen W.S. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134(4):929–936. - PubMed
    1. https://ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-disea...
    1. Bezzio C., Saibeni S., Variola A. Italian group for the study of inflammatory bowel disease (IG-IBD). Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69(7):1213–1217. - PubMed